Screener
Alamar Biosciences ALMR Instruments — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Alamar Biosciences in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Alamar Biosciences’s 10-Q, filed May 8, 2026.
- Filed
- May 8, 2026, 8:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-213424
FAQ
- What is Alamar Biosciences's instruments — revenue?
- Alamar Biosciences (ALMR) reported instruments — revenue of $7.38M in Q1 2026.
- What does instruments — revenue mean?
- This metric represents the total revenue recognized from the sale or lease of proprietary proteomics instrumentation systems, excluding any applicable sales or value-added taxes. It reflects the commercial adoption and market penetration of the company's core hardware platform used by research and clinical laboratories for protein biomarker analysis. This revenue stream is a critical indicator of the company's installed base growth and long-term potential for recurring revenue through associated consumables and service contracts.
Ask your AI about Alamar Biosciences's instruments — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude